Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulium toxin B-induced murine dry eye model

Molecular Vision

Volumn 18, Issue , 2012, Pages 1803-1812

  Zhu, Lei ^a   Zhang, Cheng ^b   Chuck, Roy S ^b  

^a Henan Eye Institute   (China)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN B; CARBOXYMETHYLCELLULOSE; FLUOROMETHOLONE; INTERLEUKIN 1BETA; KETOROLAC; NEPAFENAC; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG EFFECT; DRUG EFFICACY; DRY EYE; FEMALE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TEAR FLOW;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZENEACETAMIDES; BOTULINUM TOXINS; CONJUNCTIVA; CORNEA; DISEASE MODELS, ANIMAL; DRY EYE SYNDROMES; FEMALE; FLUORESCEIN; FLUOROMETHOLONE; GLUCOCORTICOIDS; INTERLEUKIN-1BETA; KETOROLAC; LACRIMAL APPARATUS; MICE; MICE, INBRED CBA; OPHTHALMIC SOLUTIONS; PHENYLACETATES; TEARS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864294514     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Johnson ME, Murphy PJ. Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res 2004; 23:449-74. [PMID: 15219877]
2. Management and Therapy of Dry Eye Disease: Report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007; 5:163-78. [PMID: 17508120]
3. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000; 107:631-9. [PMID: 10768324]
4. Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 2004; 138:444-57. [PMID: 15364229]
5. De Paiva CS, Corrales RM, Villarreal AL, Farley WJ, Li DQ, Stern ME, Pflugfelder SC. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exp Eye Res 2006; 83:526-35. [PMID: 16643899]
6. Paiva CS, Pflugfelder SC. Rationale for anti-inflammatory therapy in dry eye syndrome. Arq Bras Oftalmol 2008; 71:89-95. [PMID: 19274418]
7. Suwan-apichon O, Rizen M, Rangsin R, Herretes S, Reyes JM, Lekhanont K, Chuck RS. Botulinum Toxin B-Induced Mouse Model of Keratoconjunctivitis Sicca. Invest Ophthalmol Vis Sci 2006; 47:133-9. [PMID: 16384954]
8. Park CY, Zhuang W, Lekhanont K, Zhang C, Cano M, Lee WS, Gehlbach PL, Chuck RS. Lacrimal gland inflammatory cytokine gene expression in the botulinum toxin B-induced murine dry eye model. Mol Vis 2007; 13:2222-32. [PMID: 18087241]
9. Zhu L, Shen J, Zhang C, Park CY, Kohanim S, Yew M, Parker JS, Chuck RS. Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model. Mol Vis 2009; 15:250-8. [PMID: 19190733]
10. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 2000; 41:1356-63. [PMID: 10798650]
11. Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci 2001; 42:90-5. [PMID: 11133852]
12. Stern ME, Gao J, Schwalb TA, Ngo M, Tieu DD, Chan CC, Reis BL, Whitcup SM, Thompson D, Smith JA. Conjunctival T-Cell Subpopulations in Sjögren's and Non-Sjögren's Patients with Dry Eye. Invest Ophthalmol Vis Sci 2002; 43:2609-14. [PMID: 12147592]
13. Chotikavanich S, de Paiva CS, Li DQ, Chen JJ, Bian F, Farley WJ, Pflugfelder SC. Production and Activity of Matrix Metalloproteinase-9 on the Ocular Surface Increase in Dysfunctional Tear Syndrome. Invest Ophthalmol Vis Sci 2009; 50:3203-9. [PMID: 19255163]
14. Viau S, Maire MA, Pasquis B, Grégoire S, Fourgeux C, Acar N, Bretillon L, Creuzot-Garcher CP, Joffre C. Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model. Graefes Arch Clin Exp Ophthalmol 2008; 246:857-67. [PMID: 18357464]
15. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental Dry Eye Stimulates Production of Inflammatory Cytokines and MMP-9 and Activates MAPK Signaling Pathways on the Ocular Surface. Invest Ophthalmol Vis Sci 2004; 45:4293-301. [PMID: 15557435]
16. Luo L, Li DQ, Corrales RM. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens 2005; 31:186-93. [PMID: 16163009]
17. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 2003; 136:593-602. [PMID: 14516798]
18. Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 2004; 138:444-57. [PMID: 15364229]
19. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in sjögren syndrome. Ophthalmology 1999; 106:811-6. [PMID: 10201607]
20. Gumus K, Cavanagh DH. The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca. Clin Ophthalmol 2009; 3:57-67. [PMID: 19668545]
21. Colin J. The role of NSAIDs in the management of postoperative ophthalmic inflammation. Drugs 2007; 67:1291-308. [PMID: 17547472]
22. Gaynes BI, Onyekwuluje A. Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension. Clin Ophthalmol 2008; 2:355-68. [PMID: 19668727]
23. Lekhanont K, Park CY, Smith JA, Combs JC, Preechawat P, Suwan-Apichon O, Rangsin R, Chuck RS. Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. J Ocul Pharmacol Ther 2007; 23:27-34. [PMID: 17341147]
24. El-Shazly AH, El-Gohary AA, El-Shazly LH, El-Hossary GG. Comparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits. Acta Pharm 2008; 58:163-73. [PMID: 18515226]
25. Bidgood MJ, Jamal OS, Cunningham AM, Brooks PM, Scott KF. Type IIA Secretory Phospholipase A2 Up-Regulates Cyclooxygenase-2 and Amplifies Cytokine-Mediated Prostaglandin Production in Human Rheumatoid Synoviocytes. J Immunol 2000; 165:2790-7. [PMID: 10946311]
26. Chen D, Wei Y, Li X, Epstein S, Wolosin JM, Asbell P. sPLA2- IIa is an inflammatory mediator when the ocular surface is compromised. Exp Eye Res 2009; 88:880-8. [PMID: 19116146]
27. Göbbels M, Spitznas M. Corneal epithelial permeability of dry eyes before and after treatment with artificial tears. Ophthalmology 1992; 99:873-8. [PMID: 1630776]
28. Kuppens EV, de Jong CA, Stolwijk TR, de Keizer RJ, van Best JA. Effect of timolol with and without preservative on the basal tear turnover in glaucoma. Br J Ophthalmol 1995; 79:339-42. [PMID: 7742279]
29. De Saint Jean M, Brignole F, Bringuier AF, Bauchet A, Feldmann G, Baudouin C. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 1999; 40:619-30. [PMID: 10067965]
30. Epstein SP, Chen D, Asbell PA. Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther 2009; 25:415-24. [PMID: 19857103]
31. Baudouin C, Labbé A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: The good, the bad and the ugly. Prog Retin Eye Res 2010; 29:312-34. [PMID: 20302969]
32. Ward KW. Superficial punctuate fluorescein staining of the ocular surface. Optom Vis Sci 2008; 85:8-16. [PMID: 18174837]
33. Miyata K, Amano S, Sawa M, Nishida T. A novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal epithelial permeability. Arch Ophthalmol 2003; 121:1537-9. [PMID: 14609908]